New Frontiers to Cure Alport Syndrome: COL4A3 and COL4A5 Gene Editing in Podocyte-Lineage Cells

European Journal of Human Genetics - United Kingdom
doi 10.1038/s41431-019-0537-8
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Novel Mutations in COL4A3, COL4A4, and COL4A5 in Chinese Patients With Alport Syndrome

PLoS ONE
Multidisciplinary
2017English

Novel Variants in COL4A3 and COL4A4 Are Causes of Alport Syndrome in Rio Grande Do Norte, Brazil

2019English

Introduction: The Ethical Frontiers of Gene Editing

Cambridge Quarterly of Healthcare Ethics
Legal AspectsEthicsHealthIssuesHealth Policy
2018English

Alport Retinopathy Results From "Severe" COL4A5 Mutations and Predicts Early Renal Failure

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2009English

Alport Syndrome

2020English

Toxicology and Stem Cells: New Frontiers

Altex
MedicineMedical Laboratory TechnologyPharmacology
2014English

Oligodendrocyte Lineage Cells Contribute Unique Features to Rett Syndrome Neuropathology

Journal of Neuroscience
Neuroscience
2013English

Cell Therapy for Alport Syndrome

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2009English

Indigenous Perspectives and Gene Editing in Aotearoa New Zealand

Frontiers in Bioengineering and Biotechnology
BioengineeringBiomedical EngineeringHistologyBiotechnology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy